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ABSTRACT
Background Chronic pancreatitis is associated with risk factors that may negatively affect bone metabolism and increase risk of developing 
osteoporosis and low energy fractures. We evaluated the association of osteoporosis in Danish chronic pancreatitis patients with a number 
of predefined risk factors besides pancreatic exocrine insufficiency. Methods This was a cross-sectional study of 67 outpatients conducted 
at a tertiary referral centre. Dual-energy x-ray absorptiometry scan was used to examine bone mineral density for the columnar spine 
and femoral neck. The primary outcome was to identify risk factors associated with osteoporosis in chronic pancreatitis. Several clinical 
and demographic parameters, including exocrine pancreatic insufficiency, vitamin-D level, as well as muscle function and strength were 
analysed for association with bone mineral density. Results The median age of patients was 60 years (IQR 51-68) and 40% were women. 
The prevalence of osteoporosis was 26.9% in patients compared to 9.1% in Danish citizens (OR 2.4 [95% CI; 1.0-5.7]; P=0.042). Muscle 
function (Timed Up and Go Test), 25(OH)-Vitamin-D level, and body mass index were independently associated with bone mineral density 
at the femoral neck (all p<0.001), while diabetes (P=0.03) and exocrine pancreatic insufficiency (P=0.006) were independently associated 
with bone mineral density in the columnar spine. Conclusion The risk of osteoporosis in chronic pancreatitis outpatients associates with 
several modifiable risk factors in addition to exocrine pancreatic insufficiency. This information should be implemented in outpatient 
monitoring strategies to improve bone health and decrease risk of low energy fractures.
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INTRODUCTION
Chronic pancreatitis (CP) is a progressive, inflammatory 
disease leading to fibrosis and functional impairment of 
the pancreatic gland a [1], which ultimately affects the 
exocrine and endocrine function. Exocrine pancreatic 
insufficiency (EPI) often leads to maldigestion with ensuing 
malabsorption of micronutrients such as fat-soluble 
vitamins including vitamin-D [2]. Osteoporosis is typically 
caused by an increased stochastic bone remodelling to 
meet the needs of plasma calcium homeostasis. This 
will affect the bone strength through loss of bone mass 
because of trabecular penetration. The bone is thereby 
left weakened and at increased fracture risk. The calcium 
homeostasis is influenced by several factors, and some 
of these, including vitamin-D deficiency, may negatively 
influence bone metabolism and thereby increase the risk 
for developing osteoporosis. Another predisposing factor 
for osteoporosis is inactivity. The body is programmed to 
remodel bone to strengthen the weight bearing bones and 
shed “unused” bone. If the bone is overused, microdamage 
will occur due to remodelling. Likewise, microdamage will 
also occur when bone is shed due to inactivity. Activity is 
therefore essential in osteoporosis prophylaxis [3].
In keeping with this, CP patients have several potential 
risk factors for osteoporosis and population based studies 
have shown that there is an increased incidence of low 
energy fractures in CP patients compared to matched 
control groups [3, 4].
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Albeit the increased risk of low energy fractures is 
well established at the population level, the contributing 
risk factors and their interaction are still incompletely 
understood at the individual patient level. Hence, most 
previous studies have mainly focused on EPI as a risk 
factor for osteoporosis in the context of CP and there has 
been a relative disregard of other potential risk factors 
such as excessive alcohol consumption, low body weight, 
steroid use, endocrine insufficiency, and muscle strength 
and function [5, 6, 7, 8, 9, 10, 11].
Based on this lack of information we investigated the 
association between osteoporosis and several potential 
risk factors in a population of well-characterized Danish 
CP outpatients. We hypothesized that a low bone mass 
density (BMD) would be associated with a number of 
predefined risk factors including EPI and D-vitamin 
deficiency. The aim of the study was to identify risk factors 
associated with decreased BMD.
METHODS
Study Design, Patients, and Normative Data
This was a cross-sectional study conducted at Centre 
for Pancreatic Diseases, Department of Gastroenterology 
and Hepatology, Aalborg University Hospital, Denmark 
from December 2011 through August 2015. All patients 
with CP referred to our specialised tertiary centre who 
had a recent Dual-energy X-ray Absorptiometry (DXA) 
scan (≤12 months) were included. The diagnosis of CP was 
based on the Lüneburg criteria and CP was defined as a 
score ≥4 points [12].
The prevalence of osteoporosis in patients with CP was 
compared to age and gender-matched population derived 
normative data from Danish citizens as described earlier 
by Vestergaard et al. [13].
Study Outcomes
The primary outcome was to identify risk factors 
associated with a low BMD in chronic pancreatitis.
Data Collection and Risk Factors for low BMD
Predefined risk factors for low BMD (see below), 
demographics, clinical characteristics, and medication 
were collected at the patients’ first visit in our outpatient 
clinic. The M-ANNHEIM classification system was used to 
categorise the aetiology of CP [14].
A number of risk factors that have previously been 
associated with a low BMD were collected. These were; 
gender, age, alcohol consumption [15], smoking [16, 17], 
vitamin-D levels, and EPI [5, 6, 7, 9, 18, 19], opioid treatment 
[20], diabetes [21, 22], malnutrition (BMI<18.5 kg/m2) [23, 
24], and muscle strength and function assessed by handgrip 
strength (HGS) and Timed Up and Go Test (TUG) [25].
Alcohol consumption was defined as excessive if it 
exceeded the Danish Health Authorities’ recommendations 
of a maximum 7 units of alcohol per week for women and 
14 units of alcohol per week for men. Tobacco use was 
specified as number of cigarette packs per day. Opioid use 
was arbitrary stratified into three groups; no opioids, opioids 
use <50 morphine milligram equivalents per day, and opioid 
use ≥50 morphine milligram equivalents per day.
Anthropometric Assessment
Body weight was measured to nearest 0.1 kg using 
a digital electronic weight (Seca 701, CE0108, Seca, 
Birmingham, United Kingdom). Height was measured to 
nearest 0.1 cm using a wall-mounted stadiometer (Seca 
222, CE0123, Seca, Birmingham, United Kingdom). Body 
mass index (BMI) was calculated as measured body weight 
in kilograms divided by height in meters squared (kg/m2).
Muscle Strength and Function
The HGS was used to estimate the muscle strength. It 
was measured to the nearest kg using a hydraulic hand 
dynamometer (NC70142, North Coast Medical, Arcata, CA, 
USA). The patient was sitting on a chair with the shoulder 
neutrally rotated, the elbow bend 90º, the wrist in neutral 
position, and the dynamometer in second handle position. 
HGS was measured 3 times with intervals of 10-15 seconds. 
For statistical analysis, the average HGS of the two hands’ 
highest recordings was used [25].
The TUG was used to assess the patient’s muscle 
function and mobility. It measures the time that a person 
takes to rise from a chair, walk three meters, turn around, 
walk back to the chair, and sit down. The TUG test provides 
a composite measure of muscle function, requires both 
static and dynamic balance, and has been validated in 
various patient groups [26].
Dual-energy X-ray Absorptiometry
BMD (g/cm2) for the lumbar spine (L1-L4) and right 
femoral neck were assessed using dual-energy X-ray 
absorptiometry (Hologic Discovery DXA-scanner, Hologic 
Inc., Marlborough, MA, USA). BMD was expressed as 
T-scores, as well as age- and sex-adjusted Z-scores based 
on the manufacturers reference material. Osteoporosis was 
defined according to the World Health Organization as a 
T-score ≤2.5 SD below the young adult mean and osteopenia 
was defined as a T-score between -1.0 SD and -2.5 SD below 
the young adult mean [27]. A daily quality control program 
was employed to ensure scanner reliability and coefficient of 
variations between days were <1%.
Statistical Analysis
Results are presented as means ±SD unless otherwise 
stated. Normality was checked through inspection of QQ-
plots. The prevalence of osteoporosis was compared to 
age and gender matched normative data from a population 
of Danish citizens [13] and prevalence estimates were 
reported as population proportions with odds ratios (OR) 
and 95% confidence intervals (CI). Associations between 
BMD and risk factors were analysed using univariate and 
multivariate regression analysis with backward stepwise 
elimination. Bootstrapping based on 5000 samples was 
used for internal validation of the multivariate estimates. 
To aid in interpretation of the retrieved findings, ordinal 
logistic regression was used to generate probability plots 
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illustrating the probability of having osteoporosis or 
osteopenia as a function of BMI and TUG. A p-value <0.05 
was considered significant. The software package STATA 
version 14.2 (StataCorp LP, College Station, TX) was used 
for the statistical analysis.
RESULTS
Patient Characteristics
A total of 67 patients were included. The median age was 
60 years (IQR 51-68) and 40 % were women. Table 1 reports 
demographics and clinical characteristics for all patients.
Prevalence of Osteoporosis and Osteopenia
The prevalence of osteoporosis (combined estimate for 
femoral neck and lumbar spine) in this patient group was 26.9 
% in patients with CP compared to 9.1% in the population 
of Danish citizens (OR 2.4 [95% CI; 1.0-5.7]; P=0.042). The 
prevalence of osteoporosis for the femoral neck was 18.5 % 
in CP compared to 7.3% in the Danish normative population 
(OR 2.7 [95% CI; 0.9-8.2]; P=0.058); for the columnar spine, 
the estimates were 16.9% and 4.7 % respectively (OR 4.2 
[95% CI; 1.1-15.9]; P=0.022) (Figure 1). The prevalence of 
osteoporosis for the femoral neck (18.5%) was comparable 
to that observed for the columnar spine (16.9%) (P=0.82).
The prevalence of osteopenia (combined estimate for 
femoral neck and lumbar spine) was 50.2 % in patients 
with CP; no estimates were available for osteopenia from 
the normative database.
Risk Factors Associated with Bone Mineral Density
On univariate analysis two risk factors were associated 
with BMD in the columnar spine; vitamin-D level 
(coefficient 0.13 g/cm2; P=0.017) and BMI (coefficient 0.14 
g/cm2; P=0.007). For the femoral neck four risk factors 
were associated with BMD on univariate analysis; smoking 
(coefficient -0.72 g/cm2; P=0.018), EPI (coefficient -0.93 g/
cm2; P=0.016), BMI (coefficient 0.14 g/cm2; P<0.001), and 
TUG (coefficient (-0.16 g/cm2; P=0.01) (Table 2).
On multivariate analysis, diabetes (coefficient 0.96; 
P=0.03) and EPI (coefficient -1.07; P=0.006) were 
independently associated with BMD in the columnar spine, 
while TUG (coefficient -.17; P<0.001), 25(OH)-Vitamin-D 
level (0.13; P<0.001), and BMI (coefficient 0.14; P<0.001) 
were independently associated with BMD at the femoral 
neck (Table 3).
Figure 2a illustrates the risk of osteopenia and 
osteoporosis as a function of BMI and TUG. A low BMI and 
a prolonged time to complete the TUG were associated 
with an increased risk of osteoporosis (Figure 2b).
Cases
(n=67) Complete data
Demographics
Age, median years (IQR) 60 (51-68) 67 (100)
Sex, n (%)
Male 40 (60)
67 (100)
Female 27 (40)
BMI, kg/m2 22.7 (15 – 37.9) 67 (100)
Aetiology, n (%)
Alcoholic 34 (51)
66 (99)
Hereditary 18 (27)
Efferent duct factors 10 (15)
Other 5 (7)
Duration of CP, yr 4.5 (0 – 39) 67 (100)
Risk factors
Alcohol consumption, n (%)
Normal 56 (84)
66 (99)
Excessive 11 (16)
Smoking, n (%)
None 25 (37)
67 (100)<1 pack per day 22 (33)
≥1 pack per day 20 (30)
Serum 25(OH)-Vitamin-D, nmol/l 60 (10 – 175) 67 (100)
Opioid treatment, n (%)
<50 mg morphine 57 (85)
66 (99)
>50 mg morphine 10 (15)
Diabetes, n (%) 22 (33) 67 (100)
Pancreatic exocrine insufficiency, n (%)
With enzyme treatment 28 (42)
65 (97)Without enzyme 
treatment 17 (25)
Risk-inducing drugs, n (%)
Steroids 2 (3)
67 (100)
Oestrogen 1 (1,5)
Muscle parameters
Hand grip strength, kg
Right 36.9 (13 – 69) 63 (94)
Left 33.9 (9 – 70) 63 (94)
Mean 35.3 (11 – 69.5) 62 (93)
Timed Up and Go, sec 9 (4.8 – 30.8) 60 (90)
Medication
Osteoporosis medicine, n (%)
Bisphosphonate 3 (4.5)
67 (100)
Teriparatid 1 (1.5)
Vitamins, n (%)
Vitamin D 11 (16)
67 (100)
Vitamin D and calcium 10 (15)
Table 1. Demographics and clinical characteristics of the study populations.
IQR interquartile range; BMI body mass index
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DISCUSSION
We investigated the prevalence of osteoporosis and 
associated risk factors in patients with CP at a tertiary 
referral centre in Denmark. The patients had an increased 
risk of osteoporosis compared to an age- and gender 
matched normative population. Diabetes, EPI, low vitamin-D, 
low BMI, and impaired muscle function (prolonged Timed Up 
and Go test) were independently associated with decreased 
bone mineral density. Our findings underline the importance 
of systematic evaluation of bone-health in patients with CP 
even in the absence of EPI.
Prevalence of Osteoporosis
We found a more than twofold increased prevalence 
of osteoporosis in patients compared to the reference 
population. Previous studies have reported highly varying 
prevalence of osteoporosis in CP ranging from 6.7% to 34% 
[5, 6, 7, 8, 11]. These variations likely reflect differences 
in study populations including different age and gender 
distributions, as well as differences in aetiology, severity, 
duration of CP, and differences in sun exposure. The 
relatively high prevalence observed in our study may be 
explained by referral bias as patients were not consecutive 
Figure 1. Prevalence of osteoporosis.
Z-value columnar spine Z-value femoral neck
Coefficient (95% CI) P-value Coefficient (95% CI) P-value
Smoking -0.74 (-1.65 - 0.17) 0.110 -0.72 (-1.33 - -0.12) 0.018
Excessive alcohol consumption -0.88 (-2.16 - 0.41) 0.180 -0.34 (-1.20 - 0.53) 0.440
Diabetes 0.13 (-0.12 - 0.37) 0.260 0.04 (-0.12 - 0.20) 0.600
EPI -0.79 (-1.78 - 0.20) 0.120 -0.93 (-1.68 - -0.18) 0.016
EPI by enzyme treatment*
     With enzyme treatment -1.03 (-2.13 - 0.06) 0.064 -1.00 (-1.83 - -0.16) 0.020
     Without enzyme treatment -0.57 (-1.64 - 0.51) 0.300 -0.87 (-1.70 - -0.04) 0.041
25(OH)-Vitamin-D** 0.13 (0.02 - 0.24) 0.017 0.06 (-0.01 - 0.14) 0.093
BMI 0.14 (0.04 - 0.23) 0.007 0.14 (0.08 - 0.20) <0.001
Hand grip strength -0.01 (-0.05 - 0.03) 0.520 0.02 (-0.009 - 0.04) 0.200
Timed up and go -0.009 (-0.16 - 0.14) 0.900 -0.16 (-0.28 - -0.04) 0.010
Opioid treatment***
     <50 mg morphine -0.46 (-1.61 - 0.70) 0.430 -0.49 (-1.25 - 0.28) 0.210
     ≥50 mg morphine -0.17 (-1.45 - 1.11) 0.800 -0.37 (-1.22 - 0.48) 0.390
Table 2. Univariate analysis of risk factors associated with decreased bone mineral density in patients with chronic pancreatitis.
*Compared to pancreatic exocrine sufficient patients
**The coefficients are based on changes of 10 nmol/l for 25(OH)-Vitamin-D levels
***Compared to opioid naive patients
Z-value lumbar spine Z-value hip
Coefficient (95% CI) P-value Coefficient (95% CI) P-value
Diabetes 0.96 (0.09-1.82) 0.030 -
EPI -1.07 (-1.82 - -0.31) 0.006 -
25(OH)-Vitamin-D* - 0.13 (0.06 – 0.19) <0.001
BMI - 0.14 (0.08 - 0.19) <0.001
Timed up and go - -0.17 (-0.25 - -0.08) <0.001
Table 3. Multivariate analysis of risk factors associated with bone mineral density in patients with chronic pancreatitis.
*Coefficients are based on changes of 10 nmol/l for 25(OH)-Vitamin-D levels
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and that they were seen at a tertiary centre and thus it is 
likely that they comprised a cohort of CP patients with 
more advanced disease stages than observed in primary 
care or less specialised hospital facilities.
Risk factors for Osteoporosis
Our findings show that different risk factors besides 
EPI are associated with low BDM. As in several other 
studies, we found that EPI and low vitamin-D status were 
associated with a decreased BMD. EPI is present in many 
patients with CP and in the absence of appropriate enzyme 
replacement therapy; it may lead to malabsorption of 
fat and fat-soluble vitamins, including vitamin-D. The 
latter is an essential hormone for the control of intestinal 
absorption of calcium and bone mineralization and, as 
such, vitamin-D deficiency is a well-known risk factor for 
osteoporosis [28].
Low BMI was independently associated with a 
decreased BMD in the femoral neck, but not in the 
lumbar spine. Similar observations have consistently 
been reported from observational studies and meta-
analyses [22, 23, 28, 29, 30, 31]. The pathophysiological 
mechanisms underlying these observations have not been 
fully elucidated, but two mechanisms have been proposed: 
First, individuals with a high BMI conceivable have more 
adipose tissue than lean individuals and in adipose tissue 
aromatization of androgens to oestrogens may contribute 
to maintaining bone health by maintaining a higher level of 
oestrogens [23]. Second, physical activity and mechanical 
loading is essential for maintaining a normal bone health 
and strength [24]. Many studies have investigated the 
relationship between muscle function, muscle strength, 
and BMD [32, 33]. Overall, strength training does not 
affect BMD [32], whereas walking exercises significantly 
increases BMD in the femoral neck, but not in the lumbar 
spine [33]. Our findings are in line with these observations; 
hence, muscle strength was not associated with BMD, 
whereas muscle function was significantly associated with 
BMD in the femoral neck, but not the lumbar spine.
Our study showed a positive association between 
diabetes and BMD in the columnar spine. Previous studies 
have shown similar results in both type 1 and type 2 
diabetes although the fracture risk was found to be higher 
in these patients than in healthy control subjects [34], 
indicating that BMD might not be sufficient to evaluate 
bone quality in these patients.
On univariate analysis, smoking was significantly 
associated with a low BMD in the femoral neck, but the 
significance was lost in multivariate modelling. There 
have been several studies and meta-analysis investigating 
the relationship between smoking and BMD [16, 17, 34]. 
Overall studies conclude that smoking is associated with a 
decrease in BMD of the spine and femoral neck as well as an 
increased fracture risk. Many studies explain the increased 
risk of low BMD in smokers with a dose-dependent 
osteoblast inhibition and/or osteoclast activation from 
smoking leading to decreased osteogenesis and increased 
bone resorption [16]. One study hypothesized that the 
relationship between smoking and decreased BMD was 
secondary to confounding risk factors, e.g. low BMI which 
is frequently seen in heavy smokers [17]. This could 
explain why the association between smoking and BMD 
in our study was lost in the multivariate model, while BMI 
remained a significant and independent risk factor for low 
BMD.
Strengths and Limitations
Strength in the study is that a detailed stratification and 
analysis of putative risk factors was performed and when 
using the Z-score for risk factor analysis, we eliminated 
the confounding effects of age and gender that may have 
biased previous studies.
Some limitations to this study need to be underscored: 
First, the patients were not included consecutively, and 
it is therefore likely that the prevalence will differ from 
that in the general CP patients. Second, the cross-sectional 
nature precludes definitive causal inferences about the 
relationship between osteoporosis and the reported 
a b
Figure 2. (a). The risk of osteopenia and osteoporosis as a function of BMI and TUG,  (b). The TUG was associated with an increased risk of osteoporosis.
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risk factors. However, plausible biological mechanisms 
exist for all the identified risk factors and these are 
further substantiated by previous research concerning 
osteoporosis in other patient groups. Third, the relatively 
small sample size may introduce a risk of type II errors, 
which are particularly pertinent for the multivariate 
analysis and may explain why some risk factors did not 
reach independent statistical significance. Finally, the 
study was conducted at a tertiary referral centre, which 
introduce a risk for selection bias, as the patient`s disease 
stages in this setting may be more advanced than that 
observed for the average patient with CP.
To enhance knowledge on the subject, future studies 
should be performed on larger cohorts with consecutively 
inclusion.
CONCLUSION
In patients with CP, low BMI and reduced muscle 
function were identified as independent risk factors for 
osteoporosis in addition to EPI and vitamin-D deficiency. 
These findings underline the relevance of a systematic 
approach to bone health evaluation in the context of 
CP even in the absence of EPI. Additionally, focus on 
modifiable risk factors should be prioritized including, 
enzyme replacement therapy in the presence of EPI, 
and maintenance of normal nutritional state, vitamin-D 
supplementation, and physical activity to preserve muscle 
function.
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